Document Detail

Seventy-two total knee arthroplasties performed in patients with haemophilia using continuous infusion.
MedLine Citation:
PMID:  23025325     Owner:  NLM     Status:  Publisher    
Background and Objectives  Total knee replacement (TKR) is the treatment of choice in case of end-stage knee arthropathy, the main complication of haemophilia. We report here a retrospective evaluation of 72 total knee replacement in 51 haemophilia A and B patients using continuous infusion of factor concentrates (CIFC). Materials and Methods  Patients were evaluated on the basis of the following efficacy and safety criteria: range of motion, surgery-related blood loss by three different methods, factor consumption and occurrence of short and long term complications. Results  Kaplan-Meier analysis showed a removal-free survival of TKRs of 88.4% 10 years after surgery. Most patients were satisfied with their prosthesis and described pain relief and improved mobility and better quality of life after surgery. The long term follow-up showed a mean range of motion at 86° with a flexion deformity of 4°. The blood loss differed significantly according to the method used for measurement. No life-threatening bleeding occurred. Twenty six haematomas (36.1%) and 2 haemarthroses (2.7%) occurred in 38.8% of cases during the first three postoperative weeks, with no significant impact on the orthopaedic outcome. The average factor consumption during hospitalization was 79 IU/kg/day for patients with haemophilia A and 99 IU/kg/day for patients with haemophilia B. Infections occurred in 4.1% of patients. One patient with severe haemophilia A developed an inhibitor. Conclusions  The multidisciplinary approach and the homogeneous management of our large cohort allowed the achievement of excellent functional results. Our results confirmed previously reported data on the safety and efficacy of CIFC in situations requiring intensive factor replacement, such as TKR surgery.
Y Chevalier; Y Dargaud; A Lienhart; V Chamouard; C Negrier
Related Documents :
20216535 - A long-term follow-up study on endoscopic management of children and adolescents with c...
24164935 - Improving arteriovenous fistula rate: effect on hemodialysis quality.
24327455 - Pedicled no-touch saphenous vein graft harvest limits vascular smooth muscle cell activ...
9501815 - Prospective randomized double-blind trial of neurolytic coeliac plexus block in patient...
20804485 - Transurethral incision of congenital obstructive lesions in the posterior urethra in bo...
24030345 - Clinical efficacy and determinants of response to treatment with desmopressin in mild h...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-2
Journal Detail:
Title:  Vox sanguinis     Volume:  -     ISSN:  1423-0410     ISO Abbreviation:  Vox Sang.     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-2     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0413606     Medline TA:  Vox Sang     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2012 The Author(s). Vox Sanguinis © 2012 International Society of Blood Transfusion.
Clinical Haemostasis Unit, Hopital Edouard Herriot, Lyon, France Faculté de Médecine Lyon Est, University Lyon 1, Lyon, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Electrosteric Stabilization and Its Role on Cooperative Magnetophoresis of Colloidal Magnetic Nanopa...
Next Document:  The modified Medical Research Council scale for the assessment of dyspnea in daily living in obesity...